---
title: "Zepp Health surges 11% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305691112.md"
description: "Zepp Health rose 11.15% to US$3.090. Up 34.08% over ten sessions and down 88.90% YTD."
datetime: "2026-11-16T14:54:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305691112.md)
  - [en](https://longbridge.com/en/news/305691112.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305691112.md)
generator: "portal-rs"
---

# Zepp Health surges 11% during regular trading

Zepp Health (ZEPP.US) surged more than **11%** during regular trading to **$3.09**.

The stock is up 34.08% over the past ten sessions and down 88.90% year to date. It sits 43.72% above its 52-week low of US$2.150. Volume was 2.61 times its average.

The Nasdaq Composite is down 1.82% over the past five sessions and up 6.67% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ZEPP.US](https://longbridge.com/en/quote/ZEPP.US.md)

## Related News & Research

- [Space Exploration Technologies (SPCX) Gets A New Hiring Twist As Musk Eyes Top AI Talent](https://longbridge.com/en/news/306383945.md)
- [Autodesk (ADSK) Gains A New Forma Integration, Is The 34% Upside Still There?](https://longbridge.com/en/news/306363577.md)
- [Salesforce (CRM) Chosen To Lead U.S. Backed Super Intelligence Export Group](https://longbridge.com/en/news/306383121.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**